ATE325809T1 - Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure - Google Patents

Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure

Info

Publication number
ATE325809T1
ATE325809T1 AT01943442T AT01943442T ATE325809T1 AT E325809 T1 ATE325809 T1 AT E325809T1 AT 01943442 T AT01943442 T AT 01943442T AT 01943442 T AT01943442 T AT 01943442T AT E325809 T1 ATE325809 T1 AT E325809T1
Authority
AT
Austria
Prior art keywords
amino
pentoric
leucyl
tert
hydroxy
Prior art date
Application number
AT01943442T
Other languages
English (en)
Inventor
Pascal Furet
Carlos Garcia-Echeverria
Patricia Imbach
Marc Lang
Johann Zimmermann
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE325809T1 publication Critical patent/ATE325809T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT01943442T 2000-05-25 2001-05-23 Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure ATE325809T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0012795.1A GB0012795D0 (en) 2000-05-25 2000-05-25 Organic compounds

Publications (1)

Publication Number Publication Date
ATE325809T1 true ATE325809T1 (de) 2006-06-15

Family

ID=9892401

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01943442T ATE325809T1 (de) 2000-05-25 2001-05-23 Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure

Country Status (11)

Country Link
US (2) US20030166572A1 (de)
EP (1) EP1290012B1 (de)
JP (1) JP2003533541A (de)
AT (1) ATE325809T1 (de)
AU (1) AU2001266019A1 (de)
CA (1) CA2405871A1 (de)
DE (1) DE60119514T2 (de)
ES (1) ES2261422T3 (de)
GB (1) GB0012795D0 (de)
PT (1) PT1290012E (de)
WO (1) WO2001089282A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1565428A1 (de) * 2002-11-27 2005-08-24 Elan Pharmaceuticals, Inc. Substituierte harnstoffe und carbamate
GB0504950D0 (en) * 2005-03-10 2005-04-20 Novartis Ag Organic compositions
CA2604133C (en) 2005-04-07 2015-12-01 Centre National De La Recherche Scientifique Compounds useful as modulators of the proteasome activity
WO2009106574A2 (en) * 2008-02-28 2009-09-03 Novartis Ag Combinations for treating hiv-associated pain
WO2010096574A1 (en) 2009-02-20 2010-08-26 Lisanti Michael P A method of diagnosis or prognosis of a neoplasm comprising determining the level of expression of a protein in stromal cells adjacent to the neoplasm
WO2013112881A1 (en) 2012-01-27 2013-08-01 Thomas Jefferson University Mct protein inhibitor-related prognostic and therapeutic methods
WO2014172627A1 (en) 2013-04-19 2014-10-23 Thomas Jefferson University Caveolin-1 related methods for treating glioblastoma with temozolomide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538997A (en) * 1993-03-12 1996-07-23 Sandoz Ltd. 2,4-diamino-3-hydroxycarboxylic acid derivatives
EP0982317A1 (de) * 1998-08-26 2000-03-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Bivalente Proteasome Inhibitore
PT1173413E (pt) * 1999-04-27 2004-10-29 Novartis Ag Utilizacao de derivados do acido 2,4-diamino-3-hidroxicarboxilicos como inibidores de proteassoma

Also Published As

Publication number Publication date
US20060205673A1 (en) 2006-09-14
DE60119514T2 (de) 2006-10-05
EP1290012B1 (de) 2006-05-10
PT1290012E (pt) 2006-09-29
ES2261422T3 (es) 2006-11-16
JP2003533541A (ja) 2003-11-11
AU2001266019A1 (en) 2001-12-03
EP1290012A2 (de) 2003-03-12
CA2405871A1 (en) 2001-11-29
WO2001089282A3 (en) 2002-05-10
GB0012795D0 (en) 2000-07-19
DE60119514D1 (de) 2006-06-14
US20030166572A1 (en) 2003-09-04
WO2001089282A2 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
BRPI0409227B8 (pt) "composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)"
ATE504579T1 (de) Antivirale mittel
SE0101387D0 (sv) Novel compounds
BR0315547A (pt) Derivados de quinolina como antagonistas de crth2
ATE245152T1 (de) Dioxocyclopentylhydroxamsäure
MXPA04000577A (es) Derivados de dolastatina 10.
PT1404347E (pt) Nucleosidos 4'-substituidos para o tratamento de doencas mediadas pelo virus da hepatite c
WO2003053368A3 (en) Chalcone derivatives and their use to treat diseases
ATE361287T1 (de) Neue indol-2-on derivate
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
EP1689713A4 (de) Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
CY1108871T1 (el) Υποκατεστημενα παραγωγα αμινο-φουραν-2-υλ-οξεικου οξεος και αμινο-θειεν-2-οξεικου οξεος και η χρησιμοποιηση τους για τη θεραπεια ημικρανιας ή πονου
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
DE60045508D1 (de) Dalda-analoge und ihre verwendung
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
SE0302139D0 (sv) Novel compounds
ATE233754T1 (de) Diphenyl-piperidin derivate
SE9804212D0 (sv) Compounds
MXPA05010020A (es) Derivados de oxamida.
ATE267816T1 (de) Tan-1057 derivate
ATE325809T1 (de) Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure
ATE440835T1 (de) Heterozyklische harnstoff-derivate für die behandlung von schmerzen.
NO20055254D0 (no) Farmasoytisk kombinasjon for behandling av spastisitet og/eller smerte

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1290012

Country of ref document: EP

REN Ceased due to non-payment of the annual fee